StonvexLoading…
StonvexCore line items from VSH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-08-04 | Q2 2026 2026-04-04 | Annual 2025 2025-12-31 | Q3 2025 2025-09-27 | Q2 2025 2025-06-28 |
|---|---|---|---|---|---|
Revenue | $906.46M | $839.24M | $3.07B | $2.27B | $1.48B |
Operating Income | Not available | $22.12M | $56.87M | $42.08M | $22.93M |
Net Income | Not available | $7.16M | $-8.98M | $-9.96M | $-2.09M |
EPS (Diluted) | $0.16 | $0.05 | $-0.07 | $-0.07 | $-0.02 |
Total Assets | Not available | $4.26B | $4.23B | $4.20B | $4.22B |
Total Liabilities | Not available | $2.19B | $2.15B | $2.11B | $2.13B |
Cash & Equivalents | Not available | $479.36M | $514.97M | $443.86M | $473.86M |
Free Cash Flow OCF − CapEx | Not available | $-46.99M | $-88.98M | $-143.54M | $-118.86M |
Shares Outstanding | Not available | 137.47M | 135.74M | 135.74M | 135.75M |